Preoperative neutrophil-to-lymphocyte ratio as a predictive and prognostic factor for high-grade serous ovarian cancer

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Feng, Zheng ^a,b   Wen, Hao ^a,b   Bi, Rui ^a,b   Ju, Xingzhu ^a,b   Chen, Xiaojun ^a,b   Yang, Wentao ^a,b   Wu, Xiaohua ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; NEUTROPHIL LYMPHOCYTE RATIO; OVARY CANCER; OVERALL SURVIVAL; PREOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; KAPLAN MEIER METHOD; LYMPHOCYTE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; OVARY TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOCYTES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 84991518808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156101     Document Type: Article

References (20)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar; 65(2):87-108. doi: 10.3322/caac.21262 PMID: 25651787
2. Berek JS, Crum C, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2012; 119 Suppl 2:S118-S29. doi: 10.1016/S0020-7292(12)60025-3 PMID: 22999503
3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4; 144(5):646-74. doi: 10.1016/j.cell.2011.02.013 PMID: 21376230
4. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. Journal of surgical oncology. 2005 Sep 1; 91(3):181-4. PMID: 16118772
5. Goh BK, Chok AY, Allen JC Jr., Quek R, Teo MC, Chow PK, et al. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Surgery. 2015 Dec 10.
6. Han S, Liu Y, Li Q, Li Z, Hou H, Wu A. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC cancer. 2015; 15:617. doi: 10.1186/s12885-015-1629-7 PMID: 26341881
7. Zhang GM, Zhu Y, Ma XC, Qin XJ, Wan FN, Dai B, et al. Pretreatment Neutrophil-to-Lymphocyte Ratio: A Predictor of Advanced Prostate Cancer and Biochemical Recurrence in Patients Receiving Radical Prostatectomy. Medicine. 2015 Oct; 94(41):e1473. doi: 10.1097/MD.0000000000001473 PMID: 26469891
8. Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, et al. Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer. Annals of surgical oncology. 2015 Oct 28.
9. Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer immunology, immunotherapy: CII. 2009 Jan; 58(1):15-23. doi: 10.1007/s00262-008-0516-3 PMID: 18414853
10. Raungkaewmanee S, Tangjitgamol S, Manusirivithaya S, Srijaipracharoen S, Thavaramara T. Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer. Journal of gynecologic oncology. 2012 Oct; 23(4):265-73. doi: 10.3802/jgo.2012.23.4.265 PMID: 23094130
11. Kurman RJ, Shih I-M. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory. Am J Surg Pathol. 2010 Mar; 34(3):433-43. doi: 10.1097/PAS.0b013e3181cf3d79 PMID: 20154587
12. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer. Annals of surgical oncology. 2015 Nov 3.
13. Li MX, Bi XY, Li ZY, Huang Z, Han Y, Zhou JG, et al. Prognostic Role of Glasgow Prognostic Score in Patients With Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Medicine. 2015 Dec; 94(49):e2133. doi: 10.1097/MD.0000000000002133 PMID: 26656342
14. Bishara S, Griffin M, Cargill A, Bali A, Gore ME, Kaye SB, et al. Pre-treatment white blood cell subtypes as prognostic indicators in ovarian cancer. European journal of obstetrics, gynecology, and reproductive biology. 2008 May; 138(1):71-5. PMID: 17644243
15. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Critical reviews in oncology/hematology. 2013 Oct; 88(1):218-30. doi: 10.1016/j.critrevonc.2013.03.010 PMID: 23602134
16. Que Y, Qiu H, Li Y, Chen Y, Xiao W, Zhou Z, et al. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma. BMC cancer. 2015; 15:648. doi: 10.1186/s12885-015-1654-6 PMID: 26432433
17. Wang Y, Liu P, Xu Y, Zhang W, Tong L, Guo Z, et al. Preoperative neutrophil-to-lymphocyte ratio predicts response to first-line platinum-based chemotherapy and prognosis in serous ovarian cancer. Cancer chemotherapy and pharmacology. 2015 Feb; 75(2):255-62. doi: 10.1007/s00280-014-2622-6 PMID: 25428515
18. Suppan C, Bjelic-Radisic V, La Garde M, Groselj-Strele A, Eberhard K, Samonigg H, et al. Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC cancer. 2015; 15(1):1027.
19. Williams KA, Labidi-Galy SI, Terry KL, Vitonis AF, Welch WR, Goodman A, et al. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecologic oncology. 2014 Mar; 132(3):542-50. doi: 10.1016/j.ygyno.2014.01.026 PMID: 24462730
20. Zhang WW, Liu KJ, Hu GL, Liang WJ. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015 Nov; 36(11):8831-7.